Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992676 · ClinicalTrials.gov registry record
Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation
A clinical trial of Coronary Artery Disease and Sleep Disorder; Breathing-Related, sponsored by Mayo Clinic.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT04992676 is a study of Coronary Artery Disease and Sleep Disorder; Breathing-Related that has completed, run by Mayo Clinic. The registered enrollment target is 43 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04992676, a study of Coronary Artery Disease and Sleep Disorder; Breathing-Related, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine how frequently sleep disorders such as sleep disordered breathing and insomnia occur in patients with coronary artery disease enrolled in cardiac rehabilitation. By reviewing results of a variety of tests, we also hope to learn more about the cardiovascular effects on people who may have these conditions.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Polysomnograpy
- DIAGNOSTIC_TEST actigraphy
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2024-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04992676
The ClinicalTrials.gov registry entry for NCT04992676 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Polysomnograpy is the first listed.
NCT04992676 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04992676 about?
NCT04992676 is a clinical study titled "Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation". The purpose of this research is to determine how frequently sleep disorders such as sleep disordered breathing and insomnia occur in patients with coronary artery disease enrolled in cardiac rehabilitation. By reviewing results of a variety of tests, we also hope to learn more about the cardiovascul...
What is the current status of trial NCT04992676?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-08-19. Estimated completion is 2024-05-02.
What conditions does trial NCT04992676 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Sleep Disorder; Breathing-Related, Sleep Disorder; Insomnia Type.
What interventions are being tested in trial NCT04992676?
The interventions under investigation include: Polysomnograpy (DIAGNOSTIC_TEST), actigraphy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04992676?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04992676 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.